BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Vaxil Strengthens Board of Directors and Management Concurrent to $1M Financing

  Vaxil Bio is pleased to announce the addition of two veteran healthcare executives to its Board of Directors.

  December 6, 2017

   · 

  4 min read
• Ipsen Announces Its Corporate Agenda for 2018

  Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and specialty care.

  December 6, 2017

   · 

  2 min read
• Novo Nordisk: Interim Results of First-Ever Global Survey Show People With Type 2 Diabetes Underestimate Their Cardiovascular Risk

  The global survey - Taking Diabetes to Heart - developed in partnership with Novo Nordisk, runs until March 2018 and is open to all people with type 2 diabetes.

  December 6, 2017

   · 

  5 min read
• Business

  BioInvent and Transgene Collaborate on Next Generation Oncolytic Viruses Encoding an Anti-CTLA-4 Antibody to Treat Solid Tumors

  Transgene entered a collaboration to co-develop next generation oncolytic virus (OV) candidates encoding an anti-CTLA-4 antibody sequence - potentially with additional transgenes - capable of treating multiple solid tumors.

  December 6, 2017

   · 

  7 min read
• Biotech Bay

  Kalytera Confirms No Material Change in Operations

  The company confirms that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity.

  December 6, 2017

   · 

  4 min read
• Genetown

  Editas Medicine Announces Offering of Common Stock

  All of the shares in the offering are to be sold by Editas Medicine.

  December 6, 2017

   · 

  3 min read
• Business

  UH Cancer Researcher Focused on Tumor Development Research Aims to Preempt Cancer by Targeting Precursor Lesions

  A cancer researcher at the University of Houston is set to deliver an unprecedented look at the 20-year development of esophageal cancer that starts with a precancerous lesion known as “Barrett’s esophagus.”

  December 6, 2017

   · 

  4 min read
• The University of Nantes Faculty of Science & Technology Uses the Magritek Spinsolve Benchtop NMR System in the Development of New Methods Such as the Implementation of Ultrafast Quantitative 2D NMR.

  Magritek reports on the R&D work of Professor Patrick Giraudeau and his group at the University of Nantes.

  December 6, 2017

   · 

  5 min read
• EOS imaging Awarded the Prix Galien in the Medical Device Category

  The award is presented to EOS imaging in recognition of its EOS system for 2D/3D low dose imaging and associated EOSapps suite of online 3D surgical planning solutions for spine, hip and knee surgeries.

  December 6, 2017

   · 

  2 min read
• Biotech Beach

  Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 San Antonio Breast Cancer Symposium

  The presentation entitled, “Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients with HER2-positive early stage breast cancer: the CONTROL trial,” will be presented at a poster session on December 7 at 5:00 p.m. CST.

  December 6, 2017

   · 

  11 min read